# NAFDAC Outlines MedSafety and Greenbook Channels for Fake Drug Reports

> NAFDAC has opened five reporting routes, including the MedSafety and Greenbook apps, for Nigerians to flag fake, substandard and unregistered medicines.

- Published: 2026-10-24T19:25:45+00:00
- Section: Regulation & Approvals
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-24/nafdac-fake-drug-reporting-channels
- Source: [Punch Newspapers](https://punchng.com/how-to-report-suspected-fake-substandard-drugs-to-nafdac/)

## Key takeaways

- NAFDAC outlined five channels for reporting suspected fake, substandard and unregistered medicines, plus adverse reactions.
- Adverse reactions go through the MedSafety app, email or the NAFDAC e-reporting platform.
- Suspected falsified products go through the Greenbook app, the Greenbook web platform, email or the telephone number 0800-162-3322.

The National Agency for Food and Drug Administration and Control has set out the channels Nigerians can use to report suspected fake, substandard and unregistered medicines, along with adverse reactions to drugs and other regulated medical products. [Punch Newspapers](https://punchng.com/how-to-report-suspected-fake-substandard-drugs-to-nafdac/) reported the agency's guidance on October 24, 2026. NAFDAC urged consumers to supply relevant information so it can investigate products and identify potential safety concerns.

## NAFDAC's MedSafety and Greenbook Reporting Routes

In a video shared by the agency on Saturday, NAFDAC said, "If you experience an unusual or adverse reaction to a medicine, other regulated medical products or vaccines, report it through the MedSafety app available for download on the Google Play Store and the Apple App Store." Reports can also go by email or through the e-reporting platform on the agency's website.

Anyone who suspects a medical product is falsified, fake, substandard or unregistered can report it through the NAFDAC Greenbook application, also on the Google Play Store and Apple App Store. The agency said, "If you suspect that a medical product is falsified, fake, substandard or unregistered, you can report it through the NAFDAC Greenbook app." Other routes are the Greenbook web platform at greenbook.[nafdac.gov.ng](https://www.nafdac.gov.ng), email, or the telephone number 0800-162-3322.

Consumers can check a product's registration status with its registration number on the NAFDAC Automated Product Administration and Monitoring System portal at registration.nafdac.gov.ng. Regulated stakeholders recalling a product must notify NAFDAC and follow the applicable recall procedure, addressing notifications to the Director-General through the Director of Post-Marketing Surveillance. NAFDAC said, "When you report, provide as much relevant information and supporting evidence as possible."

## NAFDAC's October Enforcement Actions

NAFDAC uncovered a Lagos residential building storing over 100 sacks of empty alcoholic beverage bottles suspected for counterfeit drink production, Punch Newspapers reported in October 2026, and the bottles were destroyed to prevent reuse. The agency destroyed seized fake and substandard products valued at N2.6bn in Rivers State, including medicines, tomatoes, cookies and chemicals intercepted by Nigeria Customs Service at Onne Port between 2025 and 2026, Punch Newspapers reported that same month. NAFDAC also disowned a viral social media list claiming Nigerian products are fake, telling Nigerians to disregard it as unverified, Thenationonlineng reported in October 2026.

## Regulators in Europe and the United Kingdom

The UK's PMCPA ruled that Otsuka Europe breached 11 clauses of the marketing code after a sponsored symposium webpage promoted its Lupkynis drug off-label and omitted prescribing information, [FiercePharma](https://www.fiercepharma.com/marketing/otsuka-hit-11-marketing-code-breaches-after-event-organizer-blunder) reported on October 22, 2026. The European Medicines Agency's CHMP issued eight October decisions, including AstraZeneca's withdrawal of a prostate cancer filing and Orphelia's approval of Kizfizo for glioblastoma, [EIN Presswire](https://www.einnews.com/article/950983527/live) reported on October 19, 2026. The same committee recommended approval of Eli Lilly's weight-loss pill Foundayo, [Yahoo](https://www.yahoo.com/news/world/articles/eli-lillys-weight-loss-pill-100811325.html) reported on October 16, 2026.

## Recall Notifications and Enquiries

NAFDAC said recall notifications may include the product name, registration number, manufacturer or marketing authorisation holder, expiry date, reason for the recall, batch number, distribution details and proposed recall action. Notifications can be sent electronically through the agency's designated post-marketing surveillance channel or submitted as hard copies at the nearest NAFDAC office. Members of the public seeking clarification can call 0700-162-3322, send an email, or visit the agency's website for official information and services.

## Companies in this story

- NAFDAC · website: https://www.nafdac.gov.ng

---
News for Agent · https://newsforagent.com/llms.txt